Catalog No.
RHG58801
Species reactivity
Human, Mouse
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
IHC: 1:500-1:1000, WB: 1:500-1:1000
Target
Autosomal dominant polycystic kidney disease type II protein, TRPP2, PC2, Polycystwin, Transient receptor potential cation channel subfamily P member 2, Polycystin-2, PKD2, Polycystic kidney disease 2 protein, R48321
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q13563
Applications
IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3S80
The Diagnosis of Lupus Nephritis in A Patient with Autosomal Dominant Polycystic Kidney Disease: A Rare Case Report., PMID:40424494
A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARS-CoV-2 vaccination., PMID:40392435
Paraneoplastic systemic sclerosis: A distinct entity or a mere association - A case report., PMID:40256100
Anti-Phospholipase A2 Receptor Antibody Testing to the Rescue., PMID:40060073
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in cystic epithelial cells revealing a potential new target for polycystic kidney disease., PMID:39666736
Monocyte/macrophage pyroptosis and C5b-9-induced cyst enlargement in Pkd1-/- mice., PMID:39528237
Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a mendelian randomization study., PMID:39463412
Renal Pelvic Cancer with Multiple Lung Metastases in a Patient with Polycystic Kidney Disease, Initially Diagnosed as Non-small Cell Lung Cancer: An Autopsy Case Report., PMID:39462594
Plasma exchange-sensitive syncytial glomerulopathy in a kidney transplant patient., PMID:39162815
Repeated human leukocyte antigens eplets, importance of typing the partner., PMID:38729449
Protein kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines., PMID:38323010
Use of a donor kidney with known autosomal dominant polycystic kidney disease in a highly sensitised paediatric recipient., PMID:38231231
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in pre-cystic epithelial cells revealing a new target for polycystic kidney disease., PMID:38106222
Blood group-specific apheresis in combination with daratumumab as a rescue therapy of acute antibody-mediated rejection in a case of ABO- and human leukocyte antigen-incompatible kidney transplantation., PMID:38022864
In vivo Polycystin-1 interactome using a novel Pkd1 knock-in mouse model., PMID:37540694
Immune checkpoint activity regulates polycystic kidney disease progression., PMID:37345660
Pathophysiologic Implications and Therapeutic Approach of Klotho in Chronic Kidney Disease: A Systematic Review., PMID:37207706
Mechanism of cystogenesis by Cd79a-driven, conditional mTOR activation in developing mouse nephrons., PMID:36627370
Glucocorticoid in Combination with a TNF-α Inhibitor: Treatment of Deep Vein Thrombosis in a Patient with Behçet's Disease., PMID:36384897
Polycystin-2 (TRPP2) regulates primary cilium length in LLC-PK1 renal epithelial cells., PMID:36267587
Romosozumab successfully regulated progressive osteoporosis in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis., PMID:35980440
Outcomes of Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: Our Experience Based on 35-Years Follow-Up., PMID:35626329
Antiphospholipid Syndrome in a Patient With Autosomal Dominant Polycystic Kidney Disease: The Surface of the Moon., PMID:35547412
Pkd1 Mutation Has No Apparent Effects on Peroxisome Structure or Lipid Metabolism., PMID:35372986
SGLT2 inhibitors in non-diabetic kidney disease., PMID:35077036
B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer., PMID:35046933
Allogeneic Kidney Transplantation After COVID-19: A Case Report., PMID:34753590
Early-Isolated V Lesion in Kidney Allograft: Acute Rejection or Ischemic Injury? A Case Report of Primary Nonfunction and Graft Loss., PMID:34465423
TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease., PMID:34155062
Transient receptor potential polycystin-2 (TRPP2) regulates motility and intracellular calcium of porcine sperm., PMID:34042198
B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy., PMID:33740017
Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?, PMID:33397327
Semi-Mechanistic Pharmacokinetic Model to Guide the Dose Selection of Nimotuzumab in Patients with Autosomal Dominant Polycystic Kidney Disease., PMID:33256255
Quetiapine-induced thrombotic microangiopathy in a patient on maintenance dialysis., PMID:32981026
PKD2/polycystin-2 induces autophagy by forming a complex with BECN1., PMID:32543276
Use of Checkpoint Inhibitors in a Kidney Transplant Recipient with Metastatic Cancer., PMID:32205320
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis., PMID:31990681
Polycystin-1 Regulates Actomyosin Contraction and the Cellular Response to Extracellular Stiffness., PMID:31719603
Bilateral Nephrectomy for Adult Polycystic Kidney Disease Does Not Affect the Graft Function of Transplant Patients and Does Not Result in Sensitisation., PMID:31309115
[18F-FDG positron emission tomography in non-oncological renal pathology: Current indications and perspectives]., PMID:30982747
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis., PMID:30818997
Safe Nanocomposite-Mediated Efficient Delivery of MicroRNA Plasmids for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Therapy., PMID:30672150
Pharmacokinetic Evaluation of Nimotuzumab in Patients With Autosomal Dominant Polycystic Kidney Disease., PMID:30633365
[Nephrology : what's new in 2018 ?]., PMID:30629374
Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease., PMID:30581563
The deubiquitinating enzyme Usp14 controls ciliogenesis and Hedgehog signaling., PMID:30388222
Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange., PMID:30340563
Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition., PMID:30049680
A constitutive BCL2 down-regulation aggravates the phenotype of PKD1-mutant-induced polycystic kidney disease., PMID:28973148
Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the cpk mouse, a model of autosomal recessive polycystic kidney disease., PMID:28877884
For research use only. Not for human or drug use.
